Influence of Renal Function on the Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide as a Prognostic Cardiac Risk Marker in Patients Undergoing Noncardiac Vascular Surgery

American Journal of Cardiology

Volumn 101, Issue 1, 2008, Pages 122-126

  Goei, Dustin ^a   Schouten, Olaf ^a   Boersma, Eric ^a   Welten, Gijs M J M ^a   Dunkelgrun, Martin ^a   Lindemans, Jan ^a   van Gestel, Yvette R B M ^a   Hoeks, Sanne E ^a   Bax, Jeroen J ^b   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOCHEMICAL MARKER; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISCRIMINANT VALIDITY; DISEASE ASSOCIATION; DISEASE MARKER; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART INFARCTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; Q WAVE; RISK ASSESSMENT; VASCULAR SURGERY;

AGED; BIOLOGICAL MARKERS; DEATH, SUDDEN, CARDIAC; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL INSUFFICIENCY; SENSITIVITY AND SPECIFICITY; VASCULAR SURGICAL PROCEDURES;

EID: 37349098360     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.07.058     Document Type: Article

References (15)

1. Dernellis J., and Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 92 (2006) 1645-1650
2. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined; a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
3. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., Hogg R.J., Perrone R.D., Lau J., and Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
4. Froissart M., Rossert J., Jacquot C., Paillard M., and Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16 (2005) 763-773
5. Levey A.S., Eckardt K.U., Tsukamoto Y., Levin A., Coresh J., Rossert J., De Zeeuw D., Hostetter T.H., Lameire N., and Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
6. Hammerer-Lercher A., Puschendorf B., and Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin Lab 47 (2001) 265-277
7. Holmes S.J., Espiner E.A., Richards A.M., Yandle T.G., and Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 76 (1993) 91-96
8. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., Barnathan E.S., Califf R., Topol E.J., Simoons M.L., and Wallentin L. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
9. Takami Y., Horio T., Iwashima Y., Takiuchi S., Kamide K., Yoshihara F., Nakamura S., Nakahama H., Inenaga T., Kangawa K., and Kawano Y. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 44 (2004) 420-428
10. Anwaruddin S., Lloyd-Jones D.M., Baggish A., Chen A., Krauser D., Tung R., Chae C., and Januzzi Jr. J.L. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 (2006) 91-97
11. Khan I.A., Fink J., Nass C., Chen H., Christenson R., and deFilippi C.R. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol 97 (2006) 1530-1534
12. Landesberg G., Shatz V., Akopnik I., Wolf Y.G., Mayer M., Berlatzky Y., Weissman C., and Mosseri M. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 42 (2003) 1547-1554
13. Van Lente F., McErlean E.S., DeLuca S.A., Peacock W.F., Rao J.S., and Nissen S.E. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol 33 (1999) 471-478
14. Henrikson C.A., Howell E.E., Bush D.E., Miles J.S., Meininger G.R., Friedlander T., Bushnell A.C., and Chandra-Strobos N. Prognostic usefulness of marginal troponin T elevation. Am J Cardiol 93 (2004) 275-279
15. Feringa H.H., Bax J.J., de Jonge R., Elhendy A., van Domburg R.T., Dunkelgrun M., Schouten O., Karagiannis S.E., Vidakovic R., and Poldermans D. Impact of glomerular filtration rate on minor troponin T elevations for risk assessment in patients undergoing operation for abdominal aortic aneurysm or lower extremity arterial obstruction. Am J Cardiol 98 (2006) 1515-1518